A Validated Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Aliskiren Hemifumarate and Amlodipine Besylate in Pharmaceutical Dosage Form

Table 1

Optimized chromatographic conditions.

S. number	Parameter	Optimized condition
1	Column	Inertsil ODS C-8 (150 4.6 mm, 5 ) column
2	Mobile phase	Phosphate buffer pH 3 and acetonitrile in the ration of 40 : 60% v/v
3	Flow rate	1 mL/min
4	Detector	PDA detector at 237 nm
5	Injection volume	10 L
6	Temperature	30°C
7	Retention time	Aliskiren 3.98 min and amlodipine 5.14 min